Luiz H. Araujo
Universidade Federal de Minas Gerais(BR)Harvard University(US)Universidade de Brasília(BR)Universidade Federal de Pernambuco(BR)Universidade Estadual do Piauí(BR)Instituto(US)Instituto Nacional de Câncer - INCA(BR)Instituto Nacional do Câncer(BR)Hospital do Servidor Público Estadual(BR)Institute of the Americas(US)Instituto de Assistência Médica ao Servidor Público EstadualFundação Oswaldo Cruz(BR)Universidade Federal do Pará(BR)Universidade Federal Rural de Pernambuco(BR)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, Cancer Genomics and Diagnostics, Lung Cancer Research Studies, Colorectal Cancer Treatments and Studies
Most-Cited Works
- → PDL1 Regulation by p53 via miR-34(2015)664 cited
- → Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non–Small-Cell Lung Cancer: The Phase III POSEIDON Study(2022)414 cited
- → AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells(2019)354 cited
- → Randomized Phase III Trial of Single-Agent Pemetrexed Versus Carboplatin and Pemetrexed in Patients With Advanced Non–Small-Cell Lung Cancer and Eastern Cooperative Oncology Group Performance Status of 2(2013)237 cited
- → The IASLC Lung Cancer Staging Project: Analysis of Resection Margin Status and Proposals for Residual Tumor Descriptors for Non–Small Cell Lung Cancer(2019)151 cited
- → IASLC Lung Cancer Staging Project: The New Database to Inform Revisions in the Ninth Edition of the TNM Classification of Lung Cancer(2023)